• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • Pay 2021 Membership Dues
  • Our Membership
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Find a Pediatric Dermatologist (from SPD)
        • Clinical Trials
        • Patient Advisory Committee
        • Learn more about PeDRA’s efforts to build capacity for patient engagement in pediatric dermatology research.

           

  • Education and Events
        • Virtual Education
        • PeDRA Podcasts
        • Mentorship Program
        • Early Career Support
        • 2021 PeDRA Annual Conference
        • Past PeDRA Conferences
        • Upcoming Events
        • Education and Events Archive
        • Save the Date!

          The 2021 PeDRA Annual Conference will take place October 14-16, 2021 in Bethesda, MD.

           

  • Research
        • Grants & Awards
        • Studies
        • Focused Study Groups
        • Publications
        • Clinical Trials
        • Spring Funding Opportunities

          2021 Research Fellowships
          due April 1
          2021 Childhood Eczema Challenge Grant
          due May 4

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • PeDRA is an independent 501(c)(3) nonprofit organization driven by the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.

  • Member Login

Melanoma and nonmelanoma skin cancer in children and young adults

November 10, 2019 By Mike Siegel

Co-Principal Investigators:

Jen Huang, MD
Harvard Medical School

Larry Eichenfield, MD
UCSD

Overview:

This study is a collaboration of 10 major hospitals across the country with the unified goal of improving our understanding of skin cancer in children.  It is a multi-center retrospective case controlled study of all children < 20 years of age with the diagnosis of melanoma or nonmelanoma skin cancer (NMSC) over a 20 year period from 1995 to 2015.  We aimed to characterize the clinical and histopathologic features of melanoma and NMSC in children and to identify risk factors associated with development of these skin cancers, including exposure to chemotherapeutic agents, radiation therapy, immunosuppressive medications, and photosensitizing agents. 

The major goal of the study is to understand what risk factors are associated with development of melanoma and NMSC in children and young adults.  There have been no prior studies addressing this question.  By achieving our study goal, we hope to improve guidelines for skin cancer screening for children.

Status:

One publication in print – Huang, et al., 2019; (see publications page). Analysis is underway for additional publications.

This project received a 2019 PeDRA Study Support Grant to fund a biostatistician at Boston Children’s Hospital to assist in the final stages of data analysis and provide support as abstracts and manuscripts are prepared.

Filed Under: Active Studies, Skin Tumors and Reactions to Cancer Therapies

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2021 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy